IRIS
ULIVELLI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.796
EU - Europa 4.972
AS - Asia 680
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 5
SA - Sud America 5
Totale 11.477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.770
GB - Regno Unito 1.926
IE - Irlanda 914
IT - Italia 505
CN - Cina 500
SE - Svezia 499
UA - Ucraina 442
FR - Francia 253
DE - Germania 209
FI - Finlandia 112
VN - Vietnam 62
TR - Turchia 59
ES - Italia 33
CA - Canada 23
BE - Belgio 22
IN - India 15
HK - Hong Kong 12
AT - Austria 11
RU - Federazione Russa 10
AU - Australia 9
EU - Europa 7
GR - Grecia 6
NL - Olanda 6
BR - Brasile 4
IL - Israele 4
MN - Mongolia 4
PK - Pakistan 4
PL - Polonia 4
RO - Romania 4
SG - Singapore 4
IR - Iran 3
LU - Lussemburgo 3
CZ - Repubblica Ceca 2
JP - Giappone 2
LT - Lituania 2
MX - Messico 2
NG - Nigeria 2
PH - Filippine 2
SA - Arabia Saudita 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
IM - Isola di Man 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 11.477
Salva come PNG Salva come JPEG
Città #
Southend 1.830
Fairfield 976
Dublin 903
Chandler 522
Ashburn 503
Woodbridge 452
Wilmington 393
Jacksonville 364
Cambridge 340
Seattle 336
Houston 333
Ann Arbor 243
Siena 166
Princeton 159
Menlo Park 138
Beijing 115
Nanjing 113
Dong Ket 61
San Diego 60
Boardman 56
Helsinki 55
San Mateo 55
Dearborn 50
Nanchang 44
Izmir 40
Norwalk 37
Málaga 31
Shanghai 30
New York 28
Shenyang 27
Tianjin 27
Brussels 22
London 22
Milan 22
Triggiano 20
Jinan 19
Fremont 18
Changsha 17
Düsseldorf 15
Florence 15
Kunming 15
Ottawa 13
Jiaxing 12
Rome 12
Hebei 11
Vienna 11
Zhengzhou 11
Guangzhou 10
San Francisco 10
Washington 10
Cisano Bergamasco 9
Kilburn 9
Hangzhou 8
Ningbo 8
Berlin 7
Los Angeles 7
Pune 7
Arezzo 6
Falls Church 6
Tappahannock 6
Carpi 5
Edinburgh 5
Lanzhou 5
Monte 5
Pistoia 5
Redwood City 5
Sacramento 5
Toronto 5
Turin 5
Anguillara Sabazia 4
Ankara 4
Central 4
Hefei 4
Hong Kong 4
Islington 4
Monte San Savino 4
Pisa 4
Sergnano 4
Ulan Bator 4
Verona 4
Villacidro 4
Bitonto 3
Boston 3
Canberra 3
Chiswick 3
Delhi 3
Figline Valdarno 3
Groningen 3
Hounslow 3
Lappeenranta 3
Livorno 3
Melbourne 3
Norwich 3
Olgiate Molgora 3
Padova 3
Parma 3
Pescia 3
Prato 3
Sydney 3
Taizhou 3
Totale 8.995
Salva come PNG Salva come JPEG
Nome #
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 235
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 216
Multiple sclerosis incidence in Tuscany from administrative data 208
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 201
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 200
Multiple sclerosis spatial cluster in Tuscany 197
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 185
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 180
Multiple sclerosis incidence in Tuscany from administrative data 176
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 172
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 172
The Italian Multiple Sclerosis Register 171
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 168
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 162
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 158
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 157
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 154
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 154
Increasing prevalence of multiple sclerosis in Tuscany, Italy 153
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 145
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 143
A clinically silent, but severe, duodenal complication of duodopa infusion. 142
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 142
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 142
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 141
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 141
Antiparkinsonian drugs and visual hallucinations 138
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 136
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 135
The olfactory side of Parkinson disease: Relevance for clinical practice 133
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 132
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 132
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 130
Reliability of administrative data for the identification of Parkinson's disease cohorts 129
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. 129
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 129
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 128
The heart side of brain neuromodulation 127
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 126
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 125
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 124
Citalopram as treatment of depression in patients with epilepsy 124
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 123
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 122
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 122
Primary intraventricular haemorrhage in adults 122
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 121
Distinct olfactory cross-modal effects on the human motor system 120
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 120
Temporal dynamics of memory trace formation in the human prefrontal cortex. 120
Seizures after spontaneous supratentorial intracerebral hemorrhage 118
Clinical evidence of fluconazole-induced carbamazepine toxicity 118
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 117
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 117
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. 117
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 115
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 115
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 114
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 113
null 112
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 112
La distribuzione geografica della sclerosi multipla in Toscana 111
Somatosensory processing during movement observation in humans 108
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 108
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 108
null 106
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 105
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 105
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 105
Feasibility of TMS in patients with new generation cochlear implants 103
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 102
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 102
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 101
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls. 100
Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina 99
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 99
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 95
Mortality of Parkinson’s disease in Italy from 1980 to 2015 95
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 87
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 80
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 78
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 77
Association of celiac disease in patients with multiple sclerosis in Tuscany 75
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 73
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 69
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 68
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 68
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 67
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 64
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 55
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 54
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 53
Pisa syndrome in Parkinson disease 52
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 40
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 38
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 37
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 24
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 20
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 20
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 19
Totale 11.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019710 0 0 0 0 0 0 0 0 0 0 347 363
2019/20202.484 300 105 156 426 154 225 216 326 212 170 66 128
2020/20212.096 92 189 57 186 126 228 173 289 227 170 181 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.254 64 27 112 82 42 357 481 55 13 21 0 0
Totale 11.737